Anand Subramony, Ph.D. joins Micron Biomedical

Anand Subramony, Ph.D. joins Micron Biomedical

Micron Biomedical appoints former Lilly and AstraZeneca leader, Anand Subramony, Ph.D., as executive vice president, global product development and combination product commercialization as the company transitions from a platform technology to a commercial products company. The seasoned drug delivery and product development leader joins Micron Biomedical after the company recently announced multiple federal contracts for the development of novel vaccines and biosecurity therapeutics that overcome barriers of traditionally injected medicines including cold chain requirements during storage and transport, needle phobia, clinician shortages, and sharps waste requirements.

Format

JPEG

Quelle:

Micron Biomedical

Downloads